A Clinical Trial to study the effectiveness of Homoeopathy as an additional mode of treatment in combating Corona Virus infection

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2021
INTERVENTION: Intervention1: Homoeopathic Medicine: Arsenic Album, Bryonia Alba, Gelsemium, Antimonium Tartaricum, Crotalus Horridus: 100 ml water with 1 drop of indicated Homoeopathic Medicine in 30/ 200/ 1M potency every 2 hourly. Oral route of Administration. Duration of therapy will be 30 days Control Intervention1: Placebo: 100 ml Water having 1 drop of Rectified Spirit CONDITION: Health Condition 1: J80‐ Acute respiratory distress syndrome Health Condition 2: B972‐ Coronavirus as the cause of diseases classified elsewhere Health Condition 3: R05‐ Cough Health Condition 4: R060‐ Dyspnea Health Condition 5: R509‐ Fever, unspecified Health Condition 6: R068‐ Other abnormalities of breathing Health Condition 7: J128‐ Other viral pneumonia PRIMARY OUTCOME: Primary outcome of this trial will be measured in terms of clinically recovered case (Covid‐19 negative) or death.Timepoint: 21 days SECONDARY OUTCOME: Decrease in the frequency of the dosage of drugs of modern medicine/ conventional treatment according to the standard treatment protocol.Timepoint: 3 days Decrease in the usage of life supportive equipment like ventilator usage, etcTimepoint: 5 days Improvement in the quality of life including virulent symptoms of the patientsTimepoint: 24 hours Recovery in the case where patient is experiencing severe acute respiratory syndromeTimepoint: 2 hours INCLUSION CRITERIA: â?¢Patients suffering from COVID‐19 along with subjective and objective symptoms. â?¢Patients with age groups of 5‐70 years. â?¢Patients of both genders. â?¢Patients who are willing to give informed consent.
Epistemonikos ID: d1fb4d6f65cc7260af80e40e9942fbc3f39098fa
First added on: Oct 03, 2023